Mcp

Metoclopramide, the active ingredient in Mcp, is a dopamine antagonist (antiemetic) presented as an oral tablet for oral use. It is employed to relieve nausea and vomiting, improve gastric emptying, and manage gastro‑oesophageal reflux and gastroparesis in adults.

GNH USA supplies Mcp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the gastrointestinal and central nervous systems to control nausea, vomiting and motility disorders. - Nausea and vomiting: reduces episodes of acute and chemotherapy‑induced nausea. - Gastroparesis: accelerates gastric emptying and improves gastric symptoms. - Gastro‑oesophageal reflux disease (GERD): decreases reflux by enhancing lower‑esophageal sphincter tone. - Post‑operative nausea and vomiting: prevents and treats nausea after surgery.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness or akathisia: inner sense of agitation. - Headache: mild to moderate head pain. - Dizziness: light‑headed sensation. - Diarrhea: loose stools. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Extrapyramidal symptoms: muscle rigidity, tremor, or dystonia. - Tardive dyskinesia: irreversible involuntary movements with long‑term use. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Depression or suicidal thoughts. - Cardiac arrhythmias: irregular heart rhythms.

Before prescribing Metoclopramide, clinicians should consider several safety factors. - Assess renal function: adjust use in patients with impaired clearance. - Monitor for extrapyramidal symptoms: watch for muscle rigidity or involuntary movements. - Avoid in patients with known hypersensitivity to metoclopramide or other dopamine antagonists. - Use with caution in the elderly: increased risk of sedation and falls. - Limit duration to the shortest effective period to reduce risk of tardive dyskinesia. - Store at room temperature: keep in the original pack, protect from moisture.

Metoclopramide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Central nervous system depressants (e.g., benzodiazepines, opioids): enhanced sedation and respiratory depression. - Anticholinergic agents: increased anticholinergic burden and reduced gastrointestinal motility.

Moderate Interactions (Monitor Closely): - Opioid analgesics: may augment nausea and vomiting. - Antipsychotics (e.g., haloperidol): additive dopamine blockade, increasing extrapyramidal risk. - Selective serotonin reuptake inhibitors (SSRIs): potential for serotonin syndrome when combined with 5‑HT3 antagonism.